160 related articles for article (PubMed ID: 12270783)
1. Chemoprevention of superficial bladder cancer.
Gee J; Sabichi AL; Grossman HB
Crit Rev Oncol Hematol; 2002 Sep; 43(3):277-86. PubMed ID: 12270783
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of superficial bladder cancer.
Kamat AM
Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
[TBL] [Abstract][Full Text] [Related]
3. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
Messing E; Kim KM; Sharkey F; Schultz M; Parnes H; Kim D; Saltzstein D; Wilding G
J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of bladder cancer.
Grossman HB
Urology; 2006 Mar; 67(3 Suppl 1):19-22; discussion 23-4. PubMed ID: 16530070
[TBL] [Abstract][Full Text] [Related]
5. Retinoids in the chemoprevention of bladder cancer.
Sabichi AL; Lerner SP; Grossman HB; Lippman SM
Curr Opin Oncol; 1998 Sep; 10(5):479-84. PubMed ID: 9800121
[TBL] [Abstract][Full Text] [Related]
6. A prospective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer.
Loprinzi CL; Messing EM
J Cell Biochem Suppl; 1992; 16I():153-5. PubMed ID: 1305680
[TBL] [Abstract][Full Text] [Related]
7. The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer.
Solsona E; Iborra I; Dumont R; Rubio-Briones J; Casanova J; Almenar S
J Urol; 2000 Sep; 164(3 Pt 1):685-9. PubMed ID: 10953125
[TBL] [Abstract][Full Text] [Related]
8. Development of chemopreventive agents for bladder cancer.
Kelloff GJ; Boone CW; Malone WF; Steele VE; Doody LA
J Cell Biochem Suppl; 1992; 16I():1-12. PubMed ID: 1305671
[TBL] [Abstract][Full Text] [Related]
9. Chemoprevention of bladder cancer.
Kamat AM; Lamm DL
Urol Clin North Am; 2002 Feb; 29(1):157-68. PubMed ID: 12109342
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention of bladder cancer.
Golijanin DJ; Kakiashvili D; Madeb RR; Messing EM; Lerner SP
World J Urol; 2006 Nov; 24(5):445-72. PubMed ID: 17048030
[No Abstract] [Full Text] [Related]
11. Bladder cancer: chemoprevention, complementary approaches and budgetary considerations.
Grossman HB; Stenzl A; Moyad MA; Droller MJ
Scand J Urol Nephrol Suppl; 2008 Sep; (218):213-33. PubMed ID: 18815935
[TBL] [Abstract][Full Text] [Related]
12. Bladder Cancer Chemopreventive Agents: Current Knowledge and Concepts.
Khajeh NR; Khoyilar C; Wu Y; Spradling K; Zi X; Youssef RF
Mini Rev Med Chem; 2018; 18(13):1143-1150. PubMed ID: 26975668
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of superficial bladder cancer.
Amling CL
Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
[TBL] [Abstract][Full Text] [Related]
14. Retinoids in the prevention of bladder cancer.
Nutting CM; Huddart RA
Expert Rev Anticancer Ther; 2001 Dec; 1(4):541-5. PubMed ID: 12113086
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end point.
Decensi A; Torrisi R; Bruno S; Costantini M; Curotto A; Nicolò G; Malcangi B; Baglietto L; Bruttini GP; Gatteschi B; Rondanina G; Varaldo M; Perloff M; Malone WF; Bruzzi P
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1071-8. PubMed ID: 11045790
[TBL] [Abstract][Full Text] [Related]
16. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group.
Kurth KH; Bouffioux C; Sylvester R; van der Meijden AP; Oosterlinck W; Brausi M
Eur Urol; 2000; 37 Suppl 3():1-9. PubMed ID: 10828681
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.
Schulze M; Stotz N; Rassweiler J
J Endourol; 2007 Dec; 21(12):1533-41. PubMed ID: 18186695
[TBL] [Abstract][Full Text] [Related]
18. An overview of the treatment of superficial bladder cancer. Intravesical chemotherapy.
Duque JL; Loughlin KR
Urol Clin North Am; 2000 Feb; 27(1):125-35, x. PubMed ID: 10696251
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer.
Lum BL; Torti FM
J Natl Cancer Inst; 1991 May; 83(10):682-94. PubMed ID: 1827165
[TBL] [Abstract][Full Text] [Related]
20. Bladder cancer, 1996.
Lamm DL; Torti FM
CA Cancer J Clin; 1996; 46(2):93-112. PubMed ID: 8624800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
